{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T22:18:53Z","timestamp":1792880333888,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"18","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T00:00:00Z","timestamp":1380844800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Cancer"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejca.2013.08.006","type":"journal-article","created":{"date-parts":[[2013,9,4]],"date-time":"2013-09-04T13:15:19Z","timestamp":1378300519000},"page":"3856-3862","source":"Crossref","is-referenced-by-count":86,"title":["Diffuse intrinsic pontine glioma treated with prolonged temozolomide and radiotherapy \u2013 Results of a United Kingdom phase II trial (CNS 2007 04)"],"prefix":"10.1016","volume":"49","author":[{"given":"S.","family":"Bailey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Howman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Wheatley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Wherton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Boota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Pizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Kearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Picton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Saran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Glaser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.J.A.","family":"Connolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Hargrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejca.2013.08.006_b0005","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1470-2045(06)70615-5","article-title":"Diffuse brainstem glioma in children: critical review of clinical trials","volume":"7","author":"Hargrave","year":"2006","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0010","doi-asserted-by":"crossref","first-page":"5761","DOI":"10.1002\/cncr.24663","article-title":"Outcome and prognostic features in pediatric gliomas: a review of 6212 cases from the surveillance, epidemiology, and end results database","volume":"115","author":"Qaddoumi","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0015","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.ctrv.2011.06.007","article-title":"Diffuse intrinsic pontine gliomas: a systematic update on clinical trials and biology","volume":"38","author":"Jansen","year":"2012","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.ejca.2013.08.006_b0020","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/0360-3016(86)90325-1","article-title":"Brain stem tumors in children: results of a survey of 62 patients treated with radiotherapy","volume":"12","author":"Freeman","year":"1986","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2013.08.006_b0025","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/0360-3016(93)90228-N","article-title":"Final results of a study of escalating doses of hyperfractionated radiotherapy in brain stem tumors in children: a Pediatric Oncology Group study","volume":"27","author":"Freeman","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2013.08.006_b0030","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1002\/1097-0142(19930815)72:4<1404::AID-CNCR2820720441>3.0.CO;2-G","article-title":"Pre-irradiation chemotherapy and hyperfractionated radiation therapy 66 Gy for children with brain stem tumors. A phase II study of the Pediatric Oncology Group, Protocol 8833","volume":"72","author":"Kretschmar","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0035","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0360-3016(97)00134-X","article-title":"UKCCSG study of accelerated radiotherapy for pediatric brain stem gliomas. United Kingdom Childhood Cancer Study Group","volume":"38","author":"Lewis","year":"1997","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2013.08.006_b0040","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1002\/1097-0142(19930815)72:4<1414::AID-CNCR2820720442>3.0.CO;2-C","article-title":"Hyperfractionated radiation therapy (72 Gy) for children with brain stem gliomas. A Childrens Cancer Group Phase I\/II Trial","volume":"72","author":"Packer","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0045","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0959-8049(02)00029-1","article-title":"Carboplatin before and during radiation therapy for the treatment of malignant brain stem tumours: a study by the Societe Francaise d\u2019Oncologie Pediatrique","volume":"38","author":"Doz","year":"2002","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0050","doi-asserted-by":"crossref","first-page":"3431","DOI":"10.1200\/JCO.2002.04.109","article-title":"Preradiation chemotherapy in primary high-risk brainstem tumors: phase II study CCG-9941 of the Children\u2019s Cancer Group","volume":"20","author":"Jennings","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0055","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1002\/cncr.21403","article-title":"A phase I study of concurrent RMP-7 and carboplatin with radiation therapy for children with newly diagnosed brainstem gliomas","volume":"104","author":"Packer","year":"2005","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0060","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/(SICI)1096-911X(199801)30:1<28::AID-MPO9>3.0.CO;2-2","article-title":"Carboplatin and etoposide with hyperfractionated radiotherapy in children with newly diagnosed diffuse pontine gliomas: a phase I\/II study","volume":"30","author":"Walter","year":"1998","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0065","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1002\/pbc.21154","article-title":"Treatment of children with diffuse intrinsic brain stem glioma with radiotherapy, vincristine and oral VP-16: a Children\u2019s Oncology Group phase II study","volume":"50","author":"Korones","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0070","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<685::AID-CNCR27>3.0.CO;2-K","article-title":"Radiotherapy followed by high dose busulfan and thiotepa: a prospective assessment of high dose chemotherapy in children with diffuse pontine gliomas","volume":"88","author":"Bouffet","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0075","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1200\/JCO.2000.18.6.1246","article-title":"Radiation therapy and high-dose tamoxifen in the treatment of patients with diffuse brainstem gliomas: results of a Brazilian cooperative study. Brainstem Glioma Cooperative Group","volume":"18","author":"Broniscer","year":"2000","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.ejca.2013.08.006_b0080","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1097\/CMR.0b013e32832ccd58","article-title":"Predicting the myelotoxicity of chemotherapy: the use of pretreatment O6-methylguanine-DNA methyltransferase determination in peripheral blood mononuclear cells","volume":"20","author":"Sabharwal","year":"2011","journal-title":"Melanoma Res"},{"key":"10.1016\/j.ejca.2013.08.006_b0085","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0090","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s11060-011-0681-7","article-title":"Radiotherapy with concurrent and adjuvant temozolomide in children with newly diagnosed diffuse intrinsic pontine glioma","volume":"106","author":"Chassot","year":"2012","journal-title":"J Neurooncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0095","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1093\/neuonc\/noq205","article-title":"Temozolomide in the treatment of children with newly diagnosed diffuse intrinsic pontine gliomas: a report from the Children\u2019s Oncology Group","volume":"13","author":"Cohen","year":"2011","journal-title":"Neuro Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0100","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.ijrobp.2009.04.031","article-title":"Prospective Evaluation of Radiotherapy With Concurrent and Adjuvant Temozolomide in Children With Newly Diagnosed Diffuse Intrinsic Pontine Glioma","volume":"77","author":"Jalali","year":"2010","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ejca.2013.08.006_b0105","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1016\/j.ejca.2010.06.115","article-title":"A multi-centre Canadian pilot study of metronomic temozolomide combined with radiotherapy for newly diagnosed paediatric brainstem glioma","volume":"46","author":"Sharp","year":"2010","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0110","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1038\/sj.bjc.6600827","article-title":"Marked inactivation of O6-alkylguanine-DNA alkyltransferase activity with protracted temozolomide schedules","volume":"88","author":"Tolcher","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0115","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1200\/JCO.2007.11.5964","article-title":"Correlation of O6-methylguanine methyltransferase (MGMT) promoter methylation with clinical outcomes in glioblastoma and clinical strategies to modulate MGMT activity","volume":"26","author":"Hegi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0120","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1016\/j.ejca.2006.03.023","article-title":"Safety and pharmacokinetics of temozolomide using a dose-escalation, metronomic schedule in recurrent paediatric brain tumours","volume":"42","author":"Baruchel","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.3109\/07853890109002092","article-title":"The health utilities index (HUI) system for assessing health-related quality of life in clinical studies","volume":"33","author":"Furlong","year":"2001","journal-title":"Ann Med"},{"key":"10.1016\/j.ejca.2013.08.006_b0130","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1469-7610.1997.tb01545.x","article-title":"The strengths and difficulties questionnaire: a research note","volume":"38","author":"Goodman","year":"1997","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/j.ejca.2013.08.006_b0135","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1471-2288-3-6","article-title":"Design of phase II cancer trials evaluating survival probabilities","volume":"3","author":"Case","year":"2003","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.ejca.2013.08.006_b0140","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/cncr.23584","article-title":"Young age may predict a better outcome for children with diffuse pontine glioma","volume":"113","author":"Broniscer","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0145","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1038\/sj.bjc.6605127","article-title":"Extent of MGMT promoter methylation correlates with outcome in glioblastomas given temozolomide and radiotherapy","volume":"101","author":"Dunn","year":"2009","journal-title":"Br J Cancer"},{"issue":"8","key":"10.1016\/j.ejca.2013.08.006_b0150","first-page":"1275","article-title":"Temozolomide concomitant and adjuvant to radiotherapy in elderly patients with glioblastoma: correlation with MGMT promoter methylation status","volume":"27","author":"Brandes","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.ejca.2013.08.006_b0155","doi-asserted-by":"crossref","first-page":"4601","DOI":"10.1200\/JCO.2009.27.1932","article-title":"Temozolomide versus procarbazine, lomustine, and vincristine in recurrent high-grade glioma","volume":"28","author":"Brada","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0160","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1200\/JCO.2009.25.5463","article-title":"Whole-genome profiling of pediatric diffuse intrinsic pontine gliomas highlights platelet-derived growth factor receptor alpha and poly (ADP-ribose) polymerase as potential therapeutic targets","volume":"28","author":"Zarghooni","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0165","series-title":"Robot-guided convection-enhanced delivery of carboplatin for advanced brainstem glioma","author":"Barua","year":"2013"},{"key":"10.1016\/j.ejca.2013.08.006_b0170","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3171\/2012.10.PEDS12142","article-title":"Convection-enhanced delivery of topotecan into diffuse intrinsic brainstem tumors in children","volume":"11","author":"Anderson","year":"2013","journal-title":"J Neurosurg Pediatr"},{"key":"10.1016\/j.ejca.2013.08.006_b0175","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2217\/cns.12.15","article-title":"Pediatric diffuse intrinsic pontine glioma: can optimism replace pessimism?","volume":"1","author":"Hargrave","year":"2012","journal-title":"CNS Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0180","doi-asserted-by":"crossref","first-page":"3999","DOI":"10.1200\/JCO.2011.35.5677","article-title":"Genome-wide analyses identify recurrent amplifications of receptor tyrosine kinases and cell-cycle regulatory genes in diffuse intrinsic pontine glioma","volume":"29","author":"Paugh","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ejca.2013.08.006_b0185","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/ng.1102","article-title":"Somatic histone H3 alterations in pediatric diffuse intrinsic pontine gliomas and non-brainstem glioblastomas","volume":"44","author":"Wu","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.ejca.2013.08.006_b0190","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s00401-012-0998-0","article-title":"K27M mutation in histone H3.3 defines clinically and biologically distinct subgroups of pediatric diffuse intrinsic pontine gliomas","volume":"124","author":"Khuong-Quang","year":"2012","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.ejca.2013.08.006_b0195","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10833","article-title":"Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma","volume":"482","author":"Schwartzentruber","year":"2012","journal-title":"Nature"}],"container-title":["European Journal of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913007703?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0959804913007703?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,23]],"date-time":"2019-07-23T07:52:59Z","timestamp":1563868379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0959804913007703"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":39,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0959804913007703"],"URL":"https:\/\/doi.org\/10.1016\/j.ejca.2013.08.006","relation":{},"ISSN":["0959-8049"],"issn-type":[{"value":"0959-8049","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}